“The overall results indicate that combination treatments with β‐lapachone and genistein are more potent in killing both PC3 and LNCaP cancer cells than treatment with either genistein or β‐lapachone alone.”
“The results showed: i) that both PC3 and LNCaP are sensitive to single and combination treatments regardless of hormone sensitivity status, ii) that … both cell types correlated positively with cell death via apoptosis at lower drug concentrations and necrosis at higher concentrations, iv) that combination of genistein … β‐lapachone ….”